Focus: iRhythm Technologies is a medical device company specializing in remote cardiac monitoring, primarily through its Zio Monitor platform for arrhythmia detection and patient screening. The company operates in the cardiac diagnostics space with a focus on non-invasive continuous ECG monitoring solutions.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow iRhythm Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship continuous ECG monitoring device with clinical validation across multiple cardiac indications including arrhythmia, syncope, and hypertrophic cardiomyopathy.
Help build intelligence for iRhythm Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from iRhythm Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Extended-wear variant of Zio platform targeting specialized cardiac condition with high diagnostic complexity.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub